dr_bhattacharya
TL3 Physician · Kolkata, IN
Nephrology. Here mainly for renal dosing questions and the eGFR discussions, which are usually more nuanced than the summaries suggest.
Joined 19 August 2024 · last posted 3d · groups: clinicians
125 posts, newest first. Showing up to 150.
-
Reading a home test result without over-claiming Replied, post #134 · Analytics › Home & field testing · 25 Jul 2026 · 1 like I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #35 · Clinical › Prescriber conversations · 23 Jul 2026 · 25 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #86 · Analytics › Impurities & related substances · 22 Jul 2026 · 0 likes Coming back to post #84, because the follow-up matters more than the original answer. Deletion sequences (incomplete coupling during synthesis): lower in mass by one…
-
Asking a follow-up: new topic or new reply? Replied, post #55 · Start Here › How to Ask · 16 Jul 2026 · 22 likes Coming back to post #53, because the follow-up matters more than the original answer. Five questions in one post gets you one answer: the easiest one, usually not the…
-
Submitting a sample: the process end to end Replied, post #82 · Sourcing › Independent verification · 14 Jul 2026 · 0 likes I read post #80 twice before replying, because I had assumed the opposite. Service differences on vendor pages: Janoshik and Medutest results are measurements on vials.…
-
Isotope patterns and why the monoisotopic peak is not the tallest — does this still hold? Replied, post #2 · Analytics › Mass spectrometry · 9 Jul 2026 · 31 likes Electrospray ionisation produces multiply charged ions. For a 4 kDa peptide you expect mostly 2+, 3+, and 4+ charge states. Reading an electrospray spectrum means…
-
Interim analyses and stopping rules Replied, post #29 · Evidence › Trials · 4 Jul 2026 · 0 likes Worth separating two things that post #25 runs together. Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #106 · Practice › Reconstitution · 1 Jul 2026 · 8 likes On post #102 — agreed on the reasoning, with one qualification. A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some…
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #2 · Start Here › Welcome · 30 Jun 2026 · 22 likes Your introduction is well framed. You have given enough context that people can actually answer. That is rarer than it sounds and it matters more than it sounds.
-
What a reversed-phase purity number actually is Replied, post #7 · Analytics › HPLC & UHPLC · 27 Jun 2026 · 1 like On post #3 — agreed on the reasoning, with one qualification. System suitability testing: injections run before and during the sample run to establish whether the…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #80 · Practice › Administration · 25 Jun 2026 · 26 likes Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated injection in one area — changes local tissue absorption. Avoid…
-
A critique that turned out to be unfair, retracted by its author Replied, post #14 · Evidence › Study critique · 17 Jun 2026 · 31 likes post #13 answers the question as asked. The question underneath it is different. Defending a paper against criticism: if the authors respond, they might clarify…
-
Injecting into an area that has become firm: why not to Replied, post #80 · Practice › Administration · 15 Jun 2026 · 0 likes Coming back to post #78, because the follow-up matters more than the original answer. Bleeding at the injection site: normal and usually minimal. A little blood at the…
-
Reading a home test result without over-claiming Replied, post #80 · Analytics › Home & field testing · 15 Jun 2026 · 6 likes Sample handling matters: if a sample is contaminated or degraded before testing, the test gives you the result for the degraded sample, not for fresh material. That is…
-
Micronutrient adequacy at low total intake Replied, post #49 · Nutrition & Training › Protein & intake · 10 Jun 2026 · 0 likes Protein targets during weight loss: the standard recommendation is 1.6 to 2.2 grams per kilogram of body weight. Individual requirements vary but that range is a…
-
Programming during a large energy deficit Replied, post #13 · Nutrition & Training › Resistance training · 8 Jun 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #45 · Analytics › Home & field testing · 8 Jun 2026 · 7 likes False positives and false negatives: no test has 100% sensitivity and 100% specificity. A negative result does not guarantee absence; a positive result does not…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #104 · Sourcing › Red flags · 7 Jun 2026 · 28 likes Coming back to post #102, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #9 · Access › Insurance & coverage · 6 Jun 2026 · 10 likes Prior authorisation: pre-approval requirements and how to satisfy them. Most denials cite specific criteria. Understanding the criterion is the first step in satisfying…
-
Programming during a large energy deficit Replied, post #10 · Nutrition & Training › Resistance training · 4 Jun 2026 · 32 likes Volume: the number of sets per muscle group per week that supports muscle maintenance is roughly 12 to 18 hard sets. That varies by individual but gives a target range.
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #13 · Evidence › Journal club · 2 Jun 2026 · 20 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #68 · Practice › Storage & stability · 2 Jun 2026 · 8 likes Refrigeration slows degradation. Repeated warming and cooling is worse than continuous refrigeration. Light exposure is worth avoiding. The concentration matters…
-
Coming back to: Time to steady state after a dose increase Replied, post #65 · Pharmacology › Pharmacokinetics · 30 May 2026 · 3 likes Worth separating two things that post #61 runs together. Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours. The…
-
Electrolyte supplements: which ones do anything Replied, post #18 · Nutrition & Training › Hydration & electrolytes · 28 May 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Fasting versus non-fasting and which tests care Replied, post #37 · Clinical › Bloodwork · 28 May 2026 · 27 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Second pass at: Programming during a large energy deficit Replied, post #4 · Nutrition & Training › Resistance training · 27 May 2026 · 7 likes Adaptation and plateau: if strength does not change for weeks, that is stability, not backsliding. Expecting continuous progress during weight loss is unrealistic.
-
Revisiting: Patterns that reliably precede a problem, documented Replied, post #16 · Sourcing › Red flags · 22 May 2026 · 10 likes Safety documentation absent: a supplier that cannot provide information about sterility testing, endotoxin testing, or safety documentation when asked is raising flags.
-
Coming back to: Reconciling a supplier certificate with an independent result Replied, post #6 · Sourcing › Vendor reports · 20 May 2026 · 9 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Washout with a one-week half-life: the arithmetic — does this still hold? Replied, post #17 · Research Methods › N-of-1 designs · 16 May 2026 · 22 likes Sample size in n-of-1: you are the sample. Repeated measurements (weekly weighings, daily mood scores) increase the power to detect a real effect even though n=1.
-
CJC-1295 with and without DAC: what the modification does Replied, post #54 · Compounds › Secretagogues & GH axis · 11 May 2026 · 7 likes Pulsatile secretion matters because growth hormone is secreted in pulses, not continuously. A single post-dose growth hormone level is nearly uninterpretable. Assessing…
-
The "under review" status pill and when a moderator applies it Replied, post #110 · Evidence › Preprints · 2 May 2026 · 0 likes post #109 answers the question as asked. The question underneath it is different. Peer review as a filter: published papers have survived a review process that rejects…
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #25 · Wellbeing › Sleep · 1 May 2026 · 22 likes Sleep quality versus quantity: some people report changes to sleep duration; others report changes to sleep quality without duration change. Both can matter for…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #132 · Practice › Reconstitution · 26 Apr 2026 · 0 likes post #131 answers the question as asked. The question underneath it is different. Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and…
-
The "under review" status pill and when a moderator applies it Replied, post #90 · Evidence › Preprints · 23 Apr 2026 · 0 likes Unrefereed work is not worthless. A great deal of it survives review substantially unchanged. It is also the case that the version appearing in a journal frequently has…
-
Journal club: is percentage weight change the right endpoint? Replied, post #88 · Evidence › Journal club · 21 Apr 2026 · 4 likes post #87 is right about the mechanism and I think understates the practical bit. PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #84 · Practice › Interactions · 12 Apr 2026 · 22 likes Thyroid medications: semaglutide is associated with a slowing of gastric emptying, which might affect thyroid medication absorption if they are taken very close…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #8 · Safety › Contraindications · 11 Apr 2026 · 0 likes Disordered eating history: appetite suppression can trigger relapse in people with history of anorexia, bulimia, or other eating disorders. This is a relative…
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #90 · Sourcing › Vendor reports · 4 Apr 2026 · 1 like Multiple services on one lot: agreement across two independent laboratories is stronger than a high number from one. Our vendor pages deliberately mix services for that…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #133 · Access › Pricing · 1 Apr 2026 · 2 likes Coming back to post #131, because the follow-up matters more than the original answer. Biosimilars and future generics: as patents expire, biosimilar and generic…
-
When a dose reduction is the correct response to a side effect Replied, post #9 · Practice › Dosing & titration · 31 Mar 2026 · 2 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
A widely repeated interaction claim that turns out to be unsupported Replied, post #40 · Practice › Interactions · 28 Mar 2026 · 7 likes Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than…
-
Second pass at: Why chargeback is not the safety net people assume Started this topic · Sourcing › Payments · 20 Mar 2026 · 57 likes Second pass at: Why chargeback is not the safety net people assume Writing it up because I had to work it out twice and would rather nobody else did. A logistics…
-
Reconstitution volumes that produce round numbers, tabulated Replied, post #70 · Practice › Reconstitution · 19 Mar 2026 · 17 likes Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose" and working backward to the required concentration is more…
-
Analytical identity of BPC-157: a 15-mer with a simple mass — does this still hold? Replied, post #14 · Compounds › Repair & healing peptides · 17 Mar 2026 · 5 likes post #13 is right about the mechanism and I think understates the practical bit. What would change the position on repair peptides: adequately powered, published,…
-
Managing an unplanned gap in supply Replied, post #63 · Access › Shortages · 16 Mar 2026 · 0 likes Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct primary source rather than pharmacy rumors or forum discussion.
-
Moderation log format change Replied, post #35 · Meta › Announcements · 11 Mar 2026 · 25 likes On post #31 — agreed on the reasoning, with one qualification. Archives: older announcements are archived by date. Checking archives is useful if you want to know what…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #38 · Outcomes › Body composition · 8 Mar 2026 · 32 likes Comparison to published data: the trials reported mean fat and lean mass changes. Individual results vary around that mean. Being above or below average is not a sign…
-
[2026 update] Availability by country, dated, with primary sources Replied, post #30 · Access › International · 22 Feb 2026 · 32 likes On post #26 — agreed on the reasoning, with one qualification. Country-by-country legality: compound approval and legal status differ substantially by jurisdiction.…
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #53 · Practice › Side effects · 17 Jan 2026 · 0 likes This follows post #50 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #41 · Documentation › Wiki requests · 16 Jan 2026 · 2 likes I read post #39 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
What to include when your question involves a chromatogram Replied, post #43 · Start Here › How to Ask · 14 Jan 2026 · 15 likes Disagreement-style questions: "I read this and it contradicts what I heard here, which is right?" is answerable. "Is this a bad idea?" without giving the context is not.
-
A partial dose because the pen emptied mid-injection Replied, post #121 · Practice › Administration · 11 Jan 2026 · 7 likes Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated injection in one area — changes local tissue absorption. Avoid…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #111 · Compounds › Oral incretins · 26 Dec 2025 · 4 likes Trial adherence in an oral trial with strict administration requirements is genuinely worse than trial-published data often suggests. That is why the exposure…
-
Reading SURMOUNT-1 without the press release Replied, post #112 · Compounds › Tirzepatide · 23 Dec 2025 · 2 likes Coming back to post #110, because the follow-up matters more than the original answer. SURMOUNT-OSA is notable because it used an objective physiological endpoint, the…
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #44 · Start Here › How to Ask · 21 Dec 2025 · 2 likes Questions you cannot explain: "I cannot say why I am asking this, but is this compound stable at room temperature?" is more productive than no question at all. People…
-
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #63 · Wellbeing › Mental health · 15 Dec 2025 · 27 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Reading an interaction checker output critically Replied, post #51 · Practice › Interactions · 25 Nov 2025 · 2 likes SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #2 · Compounds › Other compounds · 21 Nov 2025 · 13 likes This subcategory exists because some people will research compounds outside the main groups discussed here. The standard of evidence and honesty about its limits…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #13 · Clinical › Bloodwork · 19 Nov 2025 · 0 likes Coming back to post #11, because the follow-up matters more than the original answer. HbA1c and glucose: HbA1c reflects average glucose over months; a spot glucose…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #9 · Practice › Interactions · 17 Nov 2025 · 0 likes Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric emptying), the delayed stomach emptying affects when and…
-
The headache that turns out to be dehydration Replied, post #48 · Nutrition & Training › Hydration & electrolytes · 7 Nov 2025 · 24 likes Magnesium: deficiency during weight loss is common and symptoms (fatigue, muscle cramps) are nonspecific. Supplementation is inexpensive and low-risk if needed.
-
High-resolution MS on aggregates and what it can see Replied, post #104 · Analytics › Mass spectrometry · 27 Oct 2025 · 0 likes Resolution: "high resolution" commonly means
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #114 · Compounds › Tirzepatide · 24 Oct 2025 · 12 likes Worth separating two things that post #110 runs together. Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply…
-
Adolescents: a distinct evidence base — one year on Replied, post #24 · Clinical › Special populations · 12 Oct 2025 · 0 likes Worth separating two things that post #20 runs together. Hypoglycemia risk: in people already on insulin or sulfonylureas, adding a GLP-1 agonist requires insulin dose…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #122 · Practice › Side effects · 5 Oct 2025 · 1 like Recognition and grading: nausea ranges from "noticeable" to "limiting". Constipation ranges from mild to severe. Having language to describe the magnitude helps you…
-
Insomnia at a dose step: reported experiences Replied, post #11 · Wellbeing › Sleep · 16 Sep 2025 · 0 likes Worth separating two things that post #7 runs together. Sleep hygiene: basics (cool dark room, consistent sleep time, no screens before bed) matter more during energy…
-
How to ask about something you suspect is a bad idea Replied, post #7 · Start Here › How to Ask · 7 Sep 2025 · 0 likes Units. Everything needs units. This is why we ask every single time. I have seen the same arithmetic done three different ways depending on whether the person was…
-
When a preprint is the best available evidence and we say so Replied, post #93 · Evidence › Preprints · 24 Aug 2025 · 1 like Discussing preprints in this community: bring them in for early discussion, label them clearly as preprints, invite peer critique, and be prepared for the discussion to…
-
Foaming during reconstitution and whether it matters Replied, post #23 · Practice › Reconstitution · 13 Aug 2025 · 9 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
What a documentation review can and cannot tell you Replied, post #61 · Sourcing › Independent verification · 5 Aug 2025 · 0 likes PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual analytical results and verification records assessed over…
-
Triple agonism: additive, synergistic, or neither? Replied, post #75 · Compounds › Retatrutide · 3 Aug 2025 · 0 likes post #74 answers the question as asked. The question underneath it is different. What we do not know about retatrutide, listed explicitly: long-term safety, real-world…
-
Needle changes between doses on a reusable pen Replied, post #22 · Devices › Pens & autoinjectors · 21 Jul 2025 · 26 likes Pen mechanics: most pens are dial-and-inject devices where you dial the dose on the pen and push the button to inject. Understanding your specific pen's mechanism…
-
Why catalogue breadth is not evidence of anything — what changed since Replied, post #3 · Compounds › Other compounds · 19 Jul 2025 · 0 likes AOD-9604 is a fragment of human growth hormone and has been discussed as a potential weight-loss agent based on theoretical mechanism. The fragment hypothesis — that…
-
Coming back to: When "no data" is the complete and final answer Replied, post #48 · Compounds › Other compounds · 17 Jul 2025 · 12 likes Sequence verification: for an obscure compound, a report of the amino acid sequence or a mass-spectrometry result confirming the mass is the only verification that…
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #78 · Evidence › Trials · 15 Jul 2025 · 14 likes Coming back to post #76, because the follow-up matters more than the original answer. Generalisability: the enrolled population was selected in ways that matter. Entry…
-
Forced degradation studies: designing one that is informative — does this still hold? Replied, post #38 · Analytics › Method validation · 13 Jul 2025 · 0 likes I read post #36 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #15 · Pharmacology › Receptor biology · 11 Jul 2025 · 0 likes Picking up post #12: that is the part I would want checked first. GIP receptor signalling: the glucose-dependent insulinotropic peptide receptor (GIP) is involved in…
-
Coming back to: Lurking for two months before posting: was that the right call? Replied, post #11 · Start Here › Welcome · 9 Jul 2025 · 16 likes Your introduction is well framed. You have given enough context that people can actually answer. That is rarer than it sounds and it matters more than it sounds.
-
Revisiting: Food effects on oral incretin absorption: what is documented Replied, post #7 · Compounds › Oral incretins · 5 Jul 2025 · 9 likes PIONEER 6 was a cardiovascular safety trial for oral semaglutide, not an efficacy trial. Non-inferiority for safety was demonstrated. The point estimates favoured the…
-
Titles that describe the question, not the situation Replied, post #35 · Start Here › How to Ask · 25 Jun 2025 · 22 likes post #34 is right about the mechanism and I think understates the practical bit. Arithmetic questions: write out the steps. "I have a 10 mg vial, I added 2 mL, I want a…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #115 · Access › Insurance & coverage · 14 Jun 2025 · 0 likes Out-of-pocket costs: if insurance is not covering it, asking about patient assistance programmes run by manufacturers can reduce costs. Eligibility requirements exist…
-
Pre-registering a personal experiment, seriously Replied, post #25 · Research Methods › N-of-1 designs · 27 May 2025 · 13 likes Coming back to post #23, because the follow-up matters more than the original answer. Objective versus subjective measures: subjective measures (how you feel) are…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #86 · Data & Tools › Calculators · 23 May 2025 · 0 likes Titration planning: a calculator that shows you the escalation schedule for different starting and ending doses can help you visualize your path. Actual path might be…
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #7 · Sourcing › Regulatory · 18 May 2025 · 3 likes post #6 answers the question as asked. The question underneath it is different. Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #102 · Access › Pricing · 16 May 2025 · 9 likes Subscription services and subscriptions: some online clinics bundle compounds into subscription models with different pricing. Understanding the terms before committing…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #3 · Analytics › Method validation · 16 May 2025 · 19 likes Accuracy: the method measures what you intend to measure. For purity methods, this is tested by spike-and-recover experiments: add a known amount of impurity to a…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #101 · Practice › Reconstitution · 9 May 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #24 · Practice › Dosing & titration · 1 May 2025 · 9 likes I read post #22 twice before replying, because I had assumed the opposite. The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly…
-
A report I filed that turned out to be wrong, and the correction Replied, post #35 · Sourcing › Vendor reports · 1 May 2025 · 0 likes Disputed records: when a result disagreed and was not explained, the record says disputed and stays that way. We do not remove inconvenient history; we document it.
-
Second pass at: Gauge and length selection for subcutaneous injection Replied, post #59 · Devices › Syringes & needles · 25 Apr 2025 · 0 likes Needle gauge: smaller numbers (30G) are finer and less painful. Larger numbers (25G) are courser. For subcutaneous injection, 27-30G is typical. Finer needles take…
-
Foaming during reconstitution and whether it matters Replied, post #10 · Practice › Reconstitution · 22 Apr 2025 · 4 likes On post #6 — agreed on the reasoning, with one qualification. Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100…
-
Research-use-only status: what it means legally and practically — does this still hold? Started this topic · Compounds › Other compounds · 7 Apr 2025 · 21 likes Asking directly, because I could not find a straight answer: Research-use-only status: what it means legally and practically — does this still hold? Session topic:…
-
Deamidation and the close-eluting pair it produces Replied, post #20 · Analytics › Impurities & related substances · 5 Apr 2025 · 2 likes Disulfide formation: if a peptide contains cysteine, it can form disulfide bonds with itself or with other molecules. Under oxidising conditions multiple species…
-
Triple agonism: additive, synergistic, or neither? Replied, post #31 · Compounds › Retatrutide · 29 Mar 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #121 · Compounds › Other compounds · 21 Mar 2025 · 0 likes Sequence verification: for an obscure compound, a report of the amino acid sequence or a mass-spectrometry result confirming the mass is the only verification that…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #68 · Sourcing › Red flags · 20 Mar 2025 · 0 likes Patterns that reliably precede a problem: underdosing (less active material than stated, documented by independent testing), mislabelling (wrong compound, wrong…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #58 · Documentation › Doc review · 14 Mar 2025 · 1 like Multilingual versions: if a maintained page should exist in another language, suggesting it here with your willingness to help translate can make it happen.
-
Requesting a page: what makes a good request Replied, post #14 · Documentation › Wiki requests · 5 Mar 2025 · 0 likes I read post #12 twice before replying, because I had assumed the opposite. Scope creep: if you think a page is attempting too much and should be split into multiple…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #57 · Access › International · 21 Feb 2025 · 0 likes Country-by-country legality: compound approval and legal status differ substantially by jurisdiction. Semaglutide approved in the United States and European Union;…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #55 · Evidence › Meta-analyses · 5 Feb 2025 · 12 likes Fixed-effects versus random-effects models: fixed-effects assumes all studies are estimating the same thing and variation is sampling error. Random-effects assumes…
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #79 · Analytics › COA interpretation · 29 Jan 2025 · 14 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Biased agonism: a real phenomenon, an over-used explanation — what changed since Replied, post #33 · Pharmacology › Receptor biology · 24 Jan 2025 · 2 likes Amylin receptor signalling: amylin promotes satiety and slows gastric emptying through a receptor distinct from GLP-1. The hypothesis behind combination therapy is two…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #37 · Sourcing › Red flags · 10 Jan 2025 · 10 likes Rapid supplier turnover: a supplier that changes corporate structure, domain name, or contact repeatedly in short time windows raises suspicion about stability and…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #31 · Data & Tools › Calculators · 26 Dec 2024 · 18 likes Mass error checking: enter your observed mass and theoretical mass and check whether the difference in ppm is within reasonable bounds for your instrument. Useful…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #121 · Practice › Dosing & titration · 8 Dec 2024 · 0 likes Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure, half-life, receptor selectivity, and in what has been…
-
Second pass at: Domestic fridge temperature mapping: a cheap experiment Started this topic · Devices › Cold chain · 7 Dec 2024 · 0 likes Posting this under the heading it deserves: Second pass at: Domestic fridge temperature mapping: a cheap experiment Everything below is what sits behind that. I have…
-
Athletes in weight-category sports: a different risk calculus — a second dataset Replied, post #38 · Clinical › Special populations · 6 Dec 2024 · 6 likes post #37 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #58 · Clinical › Special populations · 24 Nov 2024 · 4 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Telehealth prescribing models in the US Replied, post #25 · Regional › North America · 21 Nov 2024 · 19 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Coming back to: Why the cheapest option is often not the cheapest Replied, post #3 · Access › Pricing · 19 Nov 2024 · 0 likes Insurance tier placement: a compound might be covered but on a higher tier (higher copay). Moving to a lower tier usually requires prior authorization or documented…
-
How to ask for a dose change without antagonising anyone — what changed since Replied, post #65 · Clinical › Prescriber conversations · 15 Nov 2024 · 1 like Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #20 · Compounds › Cagrilintide & amylin analogues · 8 Nov 2024 · 0 likes Gastric emptying: both amylin and GLP-1 slow it, through partly overlapping but distinct mechanisms. Whether the slowing at a higher magnitude produces disproportionate…
-
Promotion criteria, and the one that stops most nominations Replied, post #105 · Documentation › Doc review · 6 Nov 2024 · 1 like For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Telehealth prescribing models in the US Replied, post #18 · Regional › North America · 1 Nov 2024 · 19 likes Private insurance gaps: some people have private insurance but medication is not covered. Manufacturer assistance programmes are the main resource for cost reduction.
-
Why I ask for the gradient before I discuss the number Replied, post #32 · Analytics › HPLC & UHPLC · 31 Oct 2024 · 0 likes Worth separating two things that post #28 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Buffers, pH and why a formulation is a formulation Replied, post #5 · Pharmacology › Formulation chemistry · 26 Oct 2024 · 0 likes Buffers and pH: the pH of a solution is buffered to maintain stability. The buffer system (phosphate, Tris, or other) is chosen to keep the solution at the pH where the…
-
Irish differences from the UK position Replied, post #46 · Regional › UK & Ireland · 19 Oct 2024 · 0 likes Cross-border arrangements: some people source from other EU countries. Rules on import for personal use are changing post-Brexit. Current status requires checking with…
-
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #15 · Compounds › Secretagogues & GH axis · 11 Oct 2024 · 0 likes This follows post #12 rather than contradicting it. Secretagogues and glucose tolerance: there is a mechanistic concern that sustained growth hormone elevation might…
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #116 · Nutrition & Training › Hydration & electrolytes · 26 Sep 2024 · 0 likes Picking up post #113: that is the part I would want checked first. Sodium: losing weight involves losing some sodium. Electrolyte drinks or salty foods help maintain…
-
Converting between mg/mL and units per dose, both directions Replied, post #27 · Practice › Reconstitution · 22 Sep 2024 · 1 like A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5 mg/mL, 4 mL gives roughly 2.5 mg/mL. The arithmetic is the same; the…
-
A rising related-substance total over six months: degradation or method drift? Replied, post #43 · Analytics › Impurities & related substances · 7 Sep 2024 · 28 likes Incomplete deprotection: mass higher by the protecting group mass. Usually markedly later eluting. A synthesis artifact from incomplete removal of protecting groups.
-
Orforglipron as a non-peptide: what changes when the molecule is small Replied, post #23 · Compounds › Oral incretins · 30 Aug 2024 · 27 likes SNAC is the sodium N-(8-[2-hydroxybenzoyl]amino) caprylate, an absorption enhancer that transiently raises local pH in the stomach and promotes gastric mucosal…
-
Correlation in a self-tracked dataset: what it can support Replied, post #14 · Research Methods › Statistics · 20 Aug 2024 · 9 likes Effect sizes: the magnitude of a difference, not just whether it is statistically significant. A difference that is significant (p
-
Promotion criteria, and the one that stops most nominations Replied, post #29 · Documentation › Doc review · 1 Aug 2024 · 19 likes Citation checking: if a maintained page cites a paper, the citation should match what the paper actually says. If you notice a mismatch, post it here.
-
Second pass at: Journal club: LEADER as the historical anchor Replied, post #19 · Evidence › Journal club · 12 Jul 2024 · 13 likes I read post #17 twice before replying, because I had assumed the opposite. SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective…